Evidence map›Paper›PMID 39671015›Full record

ArticleArchives of toxicology2025

In silico structural and mechanistic sights into the N-glycosidase mechanism of Shiga toxin.

Pavan K Madasu, Thyageshwar Chandran

Abstract read
PubMed Publisher
In one paragraph

Article in Archives of toxicology, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

2 authors.

Pavan K MadasuBiomolecular Structure and Dynamics Group, Department of Biotechnology, National Institute of Technology, #408, 4th Floor, Warangal, 506004, India.
Thyageshwar ChandranBiomolecular Structure and Dynamics Group, Department of Biotechnology, National Institute of Technology, #408, 4th Floor, Warangal, 506004, India. thyagesh@nitw.ac.in.ORCID 0000-0002-7504-1371

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Shiga toxin is the leading cause of food poisoning in the world. It is structurally similar to the plant type II ribosome-inactivating proteins (RIPs) and retains N-glycosidase activity. It acts specifically by depurinating the specific adenine A4605 of human 28S rRNA, ultimately inhibiting translation. Recent outbreaks and increasing demands for lab-scale meat assert the necessity for producing toxoids. In the current study, we have carried out the comparative structural and functional analysis of Shiga with ricin for N-glycosidase activity. Primary structural analysis indicates that Shiga is more flexible than ricin and one active site residue Gly121 (ricin), has been mutated to Ser (Shiga). Tertiary structure analysis confirms the conserved active site residue confirmation. Further, molecular dynamic studies indicate that the mutated Ser residue of Shiga imparts flexibility besides interacting with the conserved GAGA loop of 28s rRNA and contributes free energy of -5.39 kcal/mol. We have observed a decreasing trend line of average free binding energy with an average of -23 kcal/mol. The residue interaction network indicates that Arg is the key residue that protonates and initiates the N-glycosidase activity. Overall, these structural studies provide molecular insights into the N-glycosidase mechanism and serve as a prospect for the development of toxoids.

Indexed as

N-Glycosyl HydrolasesShiga ToxinCatalytic DomainHumansMolecular Dynamics SimulationMutationProtein ConformationRicinRNA, Ribosomal, 28SN-Glycosyl HydrolasesRicinRNA, Ribosomal, 28SShiga Toxin28S rRNAFood poisoningMolecular dynamic simulationsN-glycosidase mechanismShiga toxinToxoids

Identifiers

PMID39671015

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.